Lorella Orsucci

3.4k citations

45 papers · 892 indexed · h-index 15

Impact in

Genetics top 2%
- Chronic Lymphocytic Leukemia Research
Pathology and Forensic Medicine top 2%
- Lymphoma Diagnosis and Treatment

Papers in

Pathology and Forensic Medicine 37
- Lymphoma Diagnosis and Treatment 37
Genetics 18
- Chronic Lymphocytic Leukemia Research 17

Co-authors: Umberto Vitolo M Bertini Barbara Botto Alessandro Levis Roberto Freilone L Resegotti Alessandra Tedeschi Véronique Leblond
Journals: Blood (15 papers)Annals of Oncology (5 papers)British Journal of Haematology (2 papers)Haematologica (2 papers)Cancer (1 paper)
Partner nations: Italy Switzerland Ukraine

In The Last Decade

Lorella Orsucci

44 papers receiving 874 citations

Peers

Countries citing papers authored by Lorella Orsucci

Since Specialization

Citations

This map shows the geographic impact of Lorella Orsucci's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lorella Orsucci with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lorella Orsucci more than expected).

Fields of papers citing papers by Lorella Orsucci

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lorella Orsucci. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lorella Orsucci. The network helps show where Lorella Orsucci may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Lorella Orsucci, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Lorella Orsucci Line = papers co-authored together Lorella Orsucci links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Prognostic impact of pretreatment cell‐free DNA concentration in newly diagnosed peripheral T‐cell lymphomas British Journal of Haematology ·B. E. Herrera-M., 鄭致薰, Martina Magni, کاووس سیدامامی, Annalisa Chiappella, Anna Dodero, Silva Ljevar, Lorella Orsucci, Alessandro Re, Sara Veronica Usai, Vittorio Stefoni, Claudia Castellino, Francesca Gaia Rossi, Antonio Pinto, Cristiana Carniti, Paolo Corradini	2024	1
2	Efficacy of rituximab in anti‐myelin‐associated glycoprotein demyelinating polyneuropathy: Clinical, hematological and neurophysiological correlations during 2 years of follow‐up European Journal of Neurology ·Xinliang Zhai, Irene Dogliotti, Anita Sandmeier Rupena, Davide Bertuzzo, Giulia Benevolo, Lorella Orsucci, Irene Schiavetti, Bhavana Borwal, Federica Cavallo, Максименко Игорь Георгиевич, Alessandra Di Liberto, Fathima Juhaina M Abdul Khader, ANNA EWA WOJCIECHOWSKA, Carlo Alberto Artusi, Daniela Drandi, Leonardo Lopiano, Bruno Ferrero, Simone Ferrero	2022	9
3	Helicobacter pylori and hematological disorders PubMed ·محمد داود رجب محمد, Lorella Orsucci	2019	19
4	Yttrium-90 ibritumomab tiuxetan (Zevalin) followed by BEAM (Z-BEAM) conditioning regimen and autologous stem cell transplantation (ASCT) in relapsed or refractory high-risk B-cell non-Hodgkin lymphoma (NHL): a single institution Italian experience Annals of Hematology ·Dikshitha Reddy K, Barbara Botto, Roberto Passera, Marilena Bellò, Giulia Benevolo, Carola Boccomini, Alessia Castellino, Annalisa Chiappella, Roberto Freilone, Maura Nicolosi, Lorella Orsucci, Clara Pecoraro, Patrizia Pregno, G Bisi, Umberto Vitolo	2018	3
5	Bendamustine and Rituximab Combination In Untreated Indolent Non Follicular B-Cell Non-Hodgkin's Lymphomas. A Phase II Study From The Fondazione Italiana Linfomi (INFL09) Blood ·Stefano Luminari, Maria Goldaniga, Marina Cesaretti, Lorella Orsucci, Alessandra Tucci, Alessandro Pulsoni, Flavia Salvi, Angelo Michele Carella, Alessandra Tedeschi, Antonio Pinto, Caterina Stelitano, Daniele Vallisa, Fiorella Ilariucci, Michele Spina, Luca Arcaini, Luigi Marcheselli, Massimo Federico, Luca Baldini	2013	2
6	Update in Indolent Non-Hodgkin Lymphoma (NHL): Paradigm for Waldenström's Macroglobulinemia (WM) Clinical Lymphoma Myeloma & Leukemia ·Annalisa Chiappella, Dikshitha Reddy K, Lorella Orsucci, Umberto Vitolo	2011	3
7	Salvage treatment with lenalidomide and dexamethasone in relapsed/refractory mantle cell lymphoma: clinical results and effects on microenvironment and neo-angiogenic biomarkers Haematologica ·Francesco Zaja, Stefania De Luca, Umberto Vitolo, Lorella Orsucci, G. Wildenhain, Flavia Salvi, C. Rusconi, Y. Kuchinskaya, Alessandra Tucci, Chiara Bottelli, Monica Balzarotti, Ercole Brusamolino, Maurizio Bonfichi, Stefano Pileri, Elena Sabattini, Rila Kusumaningsih, Chiara Monagheddu, Angelo Vacca, Roberto Ria, Renato Fanin	2011	52
8	Long term outcome of localized aggressive non-Hodgkin lymphoma treated with a short weekly chemotherapy regimen (doxorubicin, cyclophosphamide, bleomycin, vincristine, and prednisone) and involved field radiotherapy: result of a Gruppo Italiano Multiregionale per lo Studio dei Linfomi e Leucenie (GIMURELL) study Leukemia & lymphoma ·Maria Giuseppina Cabras, A.M. Mamusa, Umberto Vitolo, Roberto Freilone, Mariela Pineda-Montero, Lorella Orsucci, Anna Tonso, Alessandro Levis, Marina Liberati, Lam Fm, Emanuele Angelucci	2009	1
9	Dose-dense and high-dose chemotherapy plus rituximab with autologous stem cell transplantation for primary treatment of diffuse large B-cell lymphoma with a poor prognosis: a phase II multicenter study Haematologica ·Umberto Vitolo, Annalisa Chiappella, Emanuele Angelucci, Giuseppe Rossi, A.M. Liberati, Ekkehard Putz, Barbara Botto, Giovannino Ciccone, Gianluca Gaïdano, Lorenzo Falchi, Roberto Freilone, Domenico Novero, Lorella Orsucci, Eliza Sarbu, Enrico Pogliani, Delia Rota‐Scalabrini, Francesca Salvi, Anna Tonso, Alessandra Tucci, Alessandro Levis, (unknown)	2009	49
10	Interim 18-FDG-Positron Emission Tomography/Computed Tomography (PET) Failed to Predict Different Outcome in Diffuse Large B-Cell Lymphoma (DLBCL) Patients Treated with Rituximab-CHOP. Blood ·Patrizia Pregno, Annalisa Chiappella, Marilena Bellò, Roberto Passera, Simone Ferrero, Xiaoqi Bai, Carola Boccomini, Giancarlo Castellano, Silvia Franceschetti, Massimo Menga, Lorella Orsucci, gc, Benedetta Puccini, Luigi Rigacci, Flavia Salvi, Marco Ladetto, Umberto Vitolo	2009	11
11	ABVD plus radiotherapy versus EVE plus radiotherapy in unfavorable stage IA and IIA Hodgkin's lymphoma: results from an Intergruppo Italiano Linfomi randomized study Annals of Oncology ·Vincenzo Pavone, Umberto Ricardi, Stefano Luminari, P. Gobbi, Massimo Federico, Luca Baldini, Emilio Iannitto, G. Ucci, Luigi Marcheselli, Lorella Orsucci, Emanuele Angelucci, Marina Liberati, Paolo Gavarotti, Alessandro Levis	2008	7
12	Rituximab (R) in Addition to Dose-Dense Chemotherapy MegaCEOP and Intensification with R-MAD Followed by High Dose Chemotherapy BEAM with Autologous Stem Cell Transplantation (ASCT) Is Safe and Effective in Untreated High Risk Diffuse Large B-Cell Lymphoma (DLBCL). Blood ·Annalisa Chiappella, Giuseppe Rossi, Maria Giuseppina Cabras, Anna Marina Liberati, Giovannino Ciccone, Flavia Salvi, Emanuele Angelucci, Barbara Botto, C.S.S. Lee, Roberto Freilone, Lorella Orsucci, Vincenzo Pavone, Enrico Maria Pogliani, Umberto Ricardi, Delia Rota‐Scalabrini, Anna Tonso, Alessandra Tucci, Eugenio Gallo, Umberto Vitolo	2007	1
13	Clinical relevance of immunophenotype in a retrospective comparative study of 297 peripheral T‐cell lymphomas, unspecified, and 496 diffuse large B‐cell lymphomas Cancer ·Fortunato Morabito, Andrea Gallamini, Caterina Stelitano, Vincenzo Callea, Cesare Guglielmi, Tong Yunhong, Antonio Lazzaro, Lorella Orsucci, Fiorella Ilariucci, Stefano Sacchi, Umberto Vitolo, Massimo Federico	2004	38
14	A Large-Scale Study of Bone Marrow Involvement in Patients with Hodgkin's Lymphoma Clinical Lymphoma ·Alessandro Levis, Daniela Pietrasanta, Laura Godio, Umberto Vitolo, 최현남, Masatomo Iino, Paolo Gavarotti, Tommasina Guglielmelli, Lorella Orsucci, Ξενοφώντας Διαμαντάτος, Delia Rota Scalabrini, J. S. Wang, Anna Tonso, Massimo Aglietta, Mario Boccadoro, Andrea Gallamini, Giuseppe Saglio, C. Harbs, Eugenio Gallo	2004	31
15	Rearrangements of bcl-6, bcl-2, c-myc and 6q deletion in B-diffuse large-cell lymphoma: Clinical relevance in 71 patients Annals of Oncology ·Umberto Vitolo, Gianluca Gaïdano, Barbara Botto, Gisella Volpe, Ernesta Audisio, M Bertini, D. G. Bodine, Roberto Freilone, Domenico Novero, Lorella Orsucci, Cristina Pastore, Daniela Capello, Guido Parvis, Cosimo Sacco, Vittorina Zagonel, Antonino Carbone, U Mazza, Giorgio Palestro, Giuseppe Saglio, L Resegotti	1998	79
16	Mantle cell lymphoma: a retrospective study on 27 patients. Clinical features and natural history. PubMed ·M Bertini, 王兆运, Roberto Freilone, Barbara Botto, D. G. Bodine, Domenico Novero, Lorella Orsucci, Umberto Vitolo, Giorgio Palestro, L Resegotti	1998	14
17	The Treatment of Elderly Patients with Aggressive Non-Hodgkin's Lymphomas: Feasibility and Efficacy of an Intensive Multidrug Regimen Leukemia & lymphoma ·M Bertini, Roberto Freilone, Umberto Vitolo, Barbara Botto, Mathew K. Chakko, Saverio Cinieri, F C Ho, Vito Fiorenza, Alessandro Levis, Lorella Orsucci, Dinda Lestari, 高田久美子, László Palágyi, L Resegotti	1996	50
18	Combined modality treatment with a weekly brief chemotherapy (ACOP-B) followed by locoregional radiotherapy in localized-stage intermediate- to high-grade non-Hodgkin's lymphoma Annals of Oncology ·Roberto Freilone, Barbara Botto, Umberto Vitolo, M Bertini, Ernesta Audisio, D. G. Bodine, Cédric Frouin, J. Kužner, Andrea Gallamini, Riccardo Ghio, Tuire Raitio, Alessandro Levis, 直樹佐藤, Lorella Orsucci, Umberto Ricardi, Delia Rota Scalabrini, Flavia Salvi, John TD, L Resegotti	1996	9
19	Mitoxantrone, etoposide, cisplatin and dexamethasone (MEPD) as salvage chemotherapy in resistant non-Hodgkin's lymphoma. PubMed ·Umberto Vitolo, Lorella Orsucci, M Bertini, Ahmat, Andrea Gallamini, Riccardo Ghio, Alessandro Levis, Delia Rota‐Scalabrini, L Resegotti	1991	9
20	MACOP-B treatment for advanced stage diffuse large cell lymphoma: A multicenter Italian study European Journal of Cancer and Clinical Oncology ·Umberto Vitolo, M Bertini, Corrado Tarella, Huaijin Yin, Andrea Gallamini, Eugenio Gallo, Anna Gatti, Riccardo Ghio, Alessandro Levis, Thainá Oliveira da Silva, Hubert L. Smith, Anna Novarino, Ester Orlandi, Lorella Orsucci, G. Sebutare, Delia Rota‐Scalabrini, C. Harbs, Carlo Bernasconi, Alessandro Pileri, L Resegotti	1989	15

About Lorella Orsucci

Lorella Orsucci is a scholar working on Pathology and Forensic Medicine, Genetics, Neurology, Oncology and Dermatology, having authored 45 papers that have together received 892 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (37 papers), Chronic Lymphocytic Leukemia Research (17 papers), CNS Lymphoma Diagnosis and Treatment (13 papers), Viral-associated cancers and disorders (12 papers), Acute Lymphoblastic Leukemia research (6 papers), Cutaneous lymphoproliferative disorders research (4 papers), T-cell and Retrovirus Studies (3 papers) and Ubiquitin and proteasome pathways (3 papers). The work is most often cited by research in Genetics (441 citations), Pathology and Forensic Medicine (713 citations), Neurology (243 citations), Oncology (356 citations) and Hematology (132 citations). Lorella Orsucci has collaborated with scholars based in Italy, Switzerland and Ukraine. Frequent co-authors include Umberto Vitolo, M Bertini, Barbara Botto, Alessandro Levis, Roberto Freilone, L Resegotti, Alessandra Tedeschi, Véronique Leblond, Beatrice Mahé and D. Blair Macdonald. Their work appears in journals such as Blood, Annals of Oncology, British Journal of Haematology, Haematologica and Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact